88 related articles for article (PubMed ID: 3359739)
1. Plasma fibronectin in mammary and uterine carcinomas.
Potazman JP; le Doussal V; Pouillard J; Jallais L; Labat-Robert J
Clin Physiol Biochem; 1988; 6(1):12-20. PubMed ID: 3359739
[TBL] [Abstract][Full Text] [Related]
2. [Determination of plasma fibronectin (Fn) levels. Comparison between normal subjects and patients with various pathological conditions].
Gironi A; Niccolai J; Fabbri LP; Niccolai M; Chisci C
Quad Sclavo Diagn; 1982 Dec; 18(4):392-405. PubMed ID: 6764670
[TBL] [Abstract][Full Text] [Related]
3. [Elevated expression of matrix metalloproteinase-9, and fibronectin concentration in recurrent epithelial ovarian cancer].
Demeter A; Szirmai K; Oláh J; Papp Z; Jeney A
Orv Hetil; 2004 Aug; 145(31):1617-24. PubMed ID: 15384859
[TBL] [Abstract][Full Text] [Related]
4. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer.
Pollmann D; Siepmann S; Geppert R; Wernecke KD; Possinger K; Lüftner D
Anticancer Res; 2007; 27(4A):1853-62. PubMed ID: 17649784
[TBL] [Abstract][Full Text] [Related]
5. Plasma and tissue fibronectin in diabetes.
Labat-Robert J; Leutenegger M; Llopis G; Ricard Y; Derouette JC
Clin Physiol Biochem; 1984; 2(1):39-48. PubMed ID: 6386277
[TBL] [Abstract][Full Text] [Related]
6. [Effects of chemotherapy on circulating angiogenic factor levels in patients with breast cancer].
Tang JH; Zhao JH; Gong JP; Qin JW; Pan LQ; Xu ZY
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):210-4. PubMed ID: 17649639
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of fibronectin and a fibronectin-like DNA-binding protein in patients with various diseases.
Todd HD; Coffee MS; Waalkes TP; Abeloff MD; Parsons RG
J Natl Cancer Inst; 1980 Nov; 65(5):901-4. PubMed ID: 6253707
[TBL] [Abstract][Full Text] [Related]
8. [Plasmafibronectin in case of tumors of the female genital system].
Tatra G; Nasr F
Strahlentherapie; 1983 Oct; 159(10):606-9. PubMed ID: 6417840
[TBL] [Abstract][Full Text] [Related]
9. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
[TBL] [Abstract][Full Text] [Related]
10. Plasma fibronectin in idiopathic myelofibrosis and related chronic myeloproliferative disorders.
Hasselbalch H; Clemmensen I
Scand J Clin Lab Invest; 1987 Sep; 47(5):429-33. PubMed ID: 3477850
[TBL] [Abstract][Full Text] [Related]
11. Prediction of prognosis and surgical indications for pulmonary metastasectomy from colorectal cancer.
Iizasa T; Suzuki M; Yoshida S; Motohashi S; Yasufuku K; Iyoda A; Shibuya K; Hiroshima K; Nakatani Y; Fujisawa T
Ann Thorac Surg; 2006 Jul; 82(1):254-60. PubMed ID: 16798225
[TBL] [Abstract][Full Text] [Related]
12. Plasma prolactin concentrations and risk of postmenopausal breast cancer.
Tworoger SS; Eliassen AH; Rosner B; Sluss P; Hankinson SE
Cancer Res; 2004 Sep; 64(18):6814-9. PubMed ID: 15375001
[TBL] [Abstract][Full Text] [Related]
13. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.
Rutkowski P; Kamińska J; Kowalska M; Ruka W; Steffen J
J Surg Oncol; 2003 Nov; 84(3):151-9. PubMed ID: 14598359
[TBL] [Abstract][Full Text] [Related]
14. [Cyclic adenosine monophosphate content in the lymphocytes of cancer patients].
Bershteĭn LM; Revskoĭ SIu; Kovaleva IG; Dil'man VM
Eksp Onkol; 1985; 7(5):53-6. PubMed ID: 2998725
[TBL] [Abstract][Full Text] [Related]
15. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
[TBL] [Abstract][Full Text] [Related]
16. Presence of erbB2 mRNA in the plasma of breast cancer patients is associated with circulating tumor cells and negative estrogen and progesterone receptor status.
Xu Y; Yao L; Li H; Ouyang T; Li J; Wang T; Fan Z; Lin B; Lu Y; Larsson O; Xie Y
Breast Cancer Res Treat; 2006 May; 97(1):49-55. PubMed ID: 16319978
[TBL] [Abstract][Full Text] [Related]
17. Clinical usefulness of serum pyridinoline cross-linked carboxyterminal telopeptide of type I collagen for diagnosis of bone metastases in patients with primary lung cancer.
Yokoyama T; Yamamoto M; Shima K; Suzuki K; Sako C; Ito G; Kume M; Maeda M
Respirology; 2005 Jun; 10(3):300-4. PubMed ID: 15955141
[TBL] [Abstract][Full Text] [Related]
18. Elevated plasma levels of ED1+ ("cellular") fibronectin in patients with vascular injury.
Peters JH; Maunder RJ; Woolf AD; Cochrane CG; Ginsberg MH
J Lab Clin Med; 1989 May; 113(5):586-97. PubMed ID: 2715681
[TBL] [Abstract][Full Text] [Related]
19. Plasma fibronectin in overweight men and women: correlation with serum triglyceride levels and serum cholinesterase activity.
Cucuianu M; Bodizs G; Duncea I; Colhon D
Blood Coagul Fibrinolysis; 1996 Nov; 7(8):779-85. PubMed ID: 9034558
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic significance of plasmatic concentration of fibronectin in patients with bronchial carcinoma].
Leonardo E; Mancuso M; Sanfilippo B; Dogliotti C; Scagliola D; Oliaro A
Minerva Med; 1985 May; 76(19-20):933-5. PubMed ID: 2987760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
